
Full profile: /officials/W000187
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
35 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-09-04
Source: Congress.gov
Currently in
This bill would make HIV prevention medications (PrEP and PEP) more accessible and affordable by improving insurance coverage and reducing out-of-pocket costs for people at risk of HIV infection. The legislation affects insurance companies, healthcare providers, and individuals seeking to prevent HIV transmission through medication rather than waiting for treatment after infection. By removing financial barriers to these preventive drugs, the bill aims to reduce new HIV cases in the United States.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.